APO IMA 400 (Imatinib Mesylate 400 mg)
Pill with imprint APO IMA 400 is Orange, Capsule-shape and has been identified as Imatinib mesylate 400 mg. It is supplied by Apotex Corp..
Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO IMA 400
More about imatinib
- Imatinib Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Other brands: Gleevec
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.